Strong FY 21 sales drives EBIT upgrade

21/01/22 -"Galenica reported strong FY21 sales growth of 10.2%, driven by 13.4% growth in the Products & Care segment and a 7.9% rise in Logistics & IT segment revenue. The former benefited from 29.2% ..."

Executive summary
Conflict of interest

Pages

Language

English

Published on

21/01/22

Download

You may also be interested by these reports :

19/04/24

Asos

Asos posted H1 24 results broadly in line with the consensus expectations. Although as had been expected the top-line and profitability continued to ...

17/04/24

DocMorris

First mover advantage – New member of our Baader Helvea Top Picks list

16/04/24

DocMorris

1Q24: Return to double-digit sales growth. CardLink approval received

10/04/24

DocMorris

Important positive news: Gematik approval for CardLink solution

EXECUTIVE SUMMARY

Updates

Pension Risks

Target & Opinion

Governance & Management

Business & Trends

Graphics : Momentum

Money Making

Graphics : MACD & Volumes

Debt

Graphics : Sensitivities

Valuation

Sector: Performance

DCF

Sector: Key data

NAV/SOTP

Sector: Ratios & Valorisation

Worth knowing

Sector: Peers

Financials

Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking

Trading in corporate shares

Analyst ownership

Advising of corporate (strategy, marketing, debt, etc)

Research paid for by corporate

Provision of corporate access paid for by corporate

Link between and a banking entity

Brokerage activity at AlphaValue